Here's What the Managers of the $6 Billion TIAA-CREF Trust Have Been Buying

Does this 10.9% dividend yield interest you?

Feb 5, 2014 at 5:36PM

Every quarter, many money managers have to disclose what they've bought and sold via "13F" filings. Their latest moves can shine a bright light on smart stock picks.

Today, let's look at the TIAA-CREF Trust Co. In case you're not aware, TIAA-CREF offers financial services to those in the fields of education, medicine, culture, government, and research. Almost 100 years old, it has a solid reputation, with 98% of its funds earning three or more stars in Morningstar ratings. The TIAA-CREF Trust Co. manages much of TIAA-CREF client money, and its reportable stock portfolio totaled $6 billion in value as of Dec. 31, 2013.

Interesting developments
So what does TIAA-CREF Trust's latest quarterly 13F filing tell us? Here are a few interesting details.

The biggest new holdings are the iShares MSCI ACWI Index ETF and the iShares Lehman Intermediate Credit Bond ETF. Other new holdings of interest include NVIDIA (NASDAQ:NVDA), one of the biggest mobile-application processor companies, which offers investors a new 2.2% dividend yield. It has had some trouble competing with Qualcomm and others in mobile processors, but its new Tegra 4 chip has some excited. Bulls like NVIDIA's entry into the mobile IP licensing business, along with its growing presence in cars and its strong position in gaming, while bears don't think it's enough of a bargain at recent levels.

Among holdings in which TIAA-CREF Trust Co. increased its stake was Gilead Sciences (NASDAQ:GILD). The company's oral hepatitis C treatment Sovaldi is on the market, with reported cure rates topping 90% in clinical trials. Gilead Sciences is well known for its success with HIV drugs  and has also recently reported promising clinical trial results for drugs treating lymphomas and blood disorders. With the stock roughly doubling over the past year, some wonder whether it's time to sell Gilead. Many remain bullish, though, with analysts at Robert W. Baird recently upping their target price and projecting that Sovaldi sales in 2014 might top $5 billion.

TIAA-CREF Trust Co. reduced its stake in lots of companies, including Exelon Corporation (NYSE:EXC), the nation's leader in nuclear energy. Exelon has been hurt by the relatively high cost of nuclear power in an environment of very low gas prices, but it has been boosted by rising electricity prices. The stock yields a hefty 4.3%, but that reflects a 41% dividend cut last year. Exelon's third-quarter numbers were solid, and bulls like its valuation and effective cost-cutting, but some worry about nuclear power's long-term prospects and whether some energy-industry regulation might hurt Exelon. Exelon has not been in the best competitive position in the past few years, but rising natural-gas prices could change that. It reports its fourth-quarter results this week.

Finally, TIAA-CREF Trust's biggest closed positions included Raytheon Company and BB&T Corporation. Other closed positions of interest include Ariad Pharmaceuticals (NASDAQ:ARIA) and Eagle Rock Energy Partners, L.P. (NASDAQ:EROC). Ariad Pharmaceuticals' leukemia drug Iclusig was approved by the FDA, but the FDA later had it pulled from the market, only to reinstate it late in the year with more restrictive labeling. Some wonder whether Ariad will be bought out, while others see it offering little beyond tax losses carried forward. Ariad does have more treatments in its pipeline, but most are based on Iclusig. Still, analysts at BMO Capital Markets recently upgraded Ariad Pharmaceuticals to outperform. It's heavily shorted, but its earnings estimates have been rising.

Eagle Rock Energy Partners, yielding 10.9%, had a lousy 2013, dropping nearly 22% while the S&P 500 gained 32%. Given its heavy debt load, some have worried about its dividend's future. (It was already cut by roughly a third last year.) Many have been heartened, though, by its decision to sell its midstream business to Regency Energy Partners for about $1.3 billion, leaving it a pure upstream master limited partnership. The cash infusion is welcome, but Eagle Rock Energy Partners will have to deploy it wisely, making some tough decisions. A further dividend cut is not out of the question.

We should never blindly copy any investor's moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing. 13F forms can be great places to find intriguing candidates for our portfolios.

The No. 1 Way to Lose Your Wealth Without Even Knowing It
You’ve fought hard to build wealth for you and your family. Yet one all-too-common pitfall could completely derail your dreams before you even know it. That's why a company The Economist hails as "an ethical oasis" has isolated five simple questions you must answer to ensure that your financial future is really secure.

Can you answer YES to all five of these eye-opening questions?
Click here to find out -- before it’s too late!

Selena Maranjianwhom you can follow on Twitter, owns  shares of Gilead Sciences and Qualcomm. The Motley Fool recommends Exelon, Gilead Sciences, Morningstar, and NIVIDIA. It owns shares of Qualcomm and Raytheon. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers